Studies at American Headache Society Meeting show promise in new migraine prevention drugs

Promising studies on three new migraine drugs in a new class — CGRP antagonists — will be presented at the American Headache Society’s annual scientific meeting. This is the first class of drugs to show the ability to actually prevent migraine attacks. —> Read More